Susana Larvie
Registered Nurse · Dover, DENPI 1265638985
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 67.4% of it on its own, with 4 other manufacturers making up the rest. Among registered nurse clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$890
- Gilead$248
- Teva Pharmaceuticals USA, Inc.$77
- Alkermes, Inc.$54
- Indivior Inc.$51
What the payments were for
- Food & beverage$1,320100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $890 |
| Gilead | 12 | $248 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Alkermes, Inc. | 3 | $54 |
| Indivior Inc. | 3 | $51 |
How this compares
$1,320 in reported general payments places this provider in the 95th percentile of 24 registered nurse providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 12 | $6,897 |
| Gabapentin | 60 | $1,682 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $1,221 |
| Ibuprofen | 46 | $481 |
| Tamsulosin Hcl | 26 | $332 |
| Atorvastatin Calcium | 27 | $330 |
| Omeprazole | 19 | $303 |
| Metformin Hcl | 32 | $244 |
| Lisinopril | 58 | $236 |
| Amlodipine Besylate | 21 | $190 |
| Hydrochlorothiazide | 38 | $151 |
| Verapamil ErVerapamil Hcl | 12 | $69 |
| Metoprolol Tartrate | 17 | $50 |
| Simvastatin | 14 | $21 |
Paid to pharmacies, not to this prescriber.
Other registered nurse in Dover
- Samantha WeissLewes$1K
- Sarah LoweLewes$267
- Gabrielle WadeMillsboro$207
- Lynn TestaiutiWilmington$184
- Krista SchoenerLewes$128
- Michele FletcherLewes$116
- Jeanna GerhardRehoboth Beach$97
- Marisa StephensNewark$76
- Debora DevuonoWilmington$76
- Loraynne WilmerNewark$67
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.